Beacon Biosignals raises $27M to scale EEG, AI-based neurobiomarker discovery platform

Neu­rotech start­up Bea­con Biosig­nals scores $27M to bring AI to EEG analy­sis (Med­C­i­ty News): Elec­troen­cephalog­ra­phy is a decades-old tech­nique for cap­tur­ing brain activ­i­ty, data that are used to eval­u­ate brain dis­or­ders. Bea­con Biosig­nals is apply­ing arti­fi­cial intel­li­gence to these tests, and the neu­rotech­nol­o­gy start­up has found a ready mar­ket in phar­ma­ceu­ti­cal com­pa­nies inter­est­ed in assess­ing how…

Read More

DARPA-funded nonsurgical neurotechnologies push the frontier of brain-machine interfaces

Rice Uni­ver­si­ty Charges Into the Future with Mag­net­ics and Bioim­plants (All About Cir­cuits): Advances in self-gen­er­at­ing drug deliv­ery sys­tems, brain-to-brain com­mu­ni­ca­tion, and injury mit­i­ga­tion tech­nolo­gies are just some of the newest research com­ing down the pipeline from Rice Uni­ver­si­ty. Sev­er­al research projects fund­ed by the Defense Advanced Research Project Agen­cy’s (DARPA) N3 pro­gram might herald…

Read More

Update: Repetitive negative thinking may increase (or perhaps be caused by) Alzheimer’s pathology

Time for a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing this month 13 research find­ings, resources and brain teasers for life­long brain and men­tal health. #1. “We found that peo­ple who exhib­it­ed high­er repet­i­tive neg­a­tive think­ing pat­terns expe­ri­enced more cog­ni­tive decline over a four-year peri­od. They also had spe­cif­ic declines in mem­o­ry (which is an ear­ly sign…

Read More

Explore The State of Noninvasive Neurotechnology in 37 minutes and 1 image

? Heads-up: The record­ings for the webi­nar on The State of Non­in­va­sive Neu­rotech­nol­o­gy, held on May 19th, are already avail­able on YouTube. Dr. Ricar­do Gil-da-Cos­­ta (above) and Alvaro Fer­nan­dez (below) gave an excel­lent out­look on the brain tech indus­try, with a deep look into apps and wear­ables and the capa­bil­i­ties that human brain could achieve.…

Read More

Reinventing depression treatment via transcranial magnetic brain stimulation (TMS)

___ Stan­ford researchers devise treat­ment that relieved depres­sion in 90% of par­tic­i­pants in small study (press release): “A new form of mag­net­ic brain stim­u­la­tion rapid­ly relieved symp­toms of severe depres­sion in 90% of par­tic­i­pants in a small study con­duct­ed by researchers at the Stan­ford Uni­ver­si­ty School of Med­i­cine … In tran­scra­nial mag­net­ic stim­u­la­tion, elec­tric currents…

Read More

McLean Hospital Corp: #16 Holder of Pervasive Neurotech Intellectual Property*

McLean Hos­pi­tal is the third old­est psy­chi­atric hos­pi­tal in the Unit­ed States and is affil­i­at­ed with Har­vard Med­ical School. McLean’s research efforts in neu­ro­science and psy­chi­a­try span 66 lab­o­ra­to­ries and near­ly 400 research staff — it claims to have the largest research pro­gram of any pri­vate psy­chi­atric hospital. 

Read More